Search earnings tickers

LLY

2024Q2BMO

Eli Lilly and Company primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Report 2024-08-08 · Fiscal end 2024-06-30 · Features as of 2024-08-07

← Earnings history

Street

Consensus EPS2.77

Consensus rev—

EPS high—

EPS low—

Dispersion—

Analysts—

EPS rev net 7d—

EPS rev net 30d—

Consensus Δ 7d—

Consensus Δ 30d—

Options

Implied move3.7%

IV front—

P/C full—

P/C front—

Features as of2024-08-07

Run-up

Close—

Ret 5d-4.0%

Ret 10d-10.2%

Ret 20d-17.8%

Ret 30d-14.6%

Print

Actual EPS

3.92Beat

Estimated EPS2.77

Actual revenue

11.3B

Surprise %+41.5%

Beat / missBeat

Beat streak 44

Beat streak 85

Reaction

1-day stock reaction-3.4%

Implied vs actual

Implied 3.7%Actual 13.3%

Gap reaction+13.3%

Day result+9.5%

Next-day upNo

Realized / IV3.57×

Post tape

Post 5d+10.2%

Post 10d+12.9%

Post volume9.4M

Vol ×10d2.42×

Vol ×20d2.62×

Post range6.0%

LLY

Pre-Earnings Data